Neuromodulation and Listening Therapy for Tinnitus
(TDCS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people with tinnitus (ringing in the ears) and hyperacusis (sensitivity to everyday sounds) by combining brain stimulation and listening therapy. The brain stimulation, known as transcranial direct current stimulation (tDCS), is a non-invasive technique that applies gentle electrical currents to the head. Participants will receive either the active treatment or a sham (inactive) version, along with active listening therapy. Individuals who have experienced tinnitus or hyperacusis for more than 8 months and find it affects their daily life may be suitable for this study. As an unphased trial, this study provides a unique opportunity to explore innovative treatment methods for those seeking relief from these conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that transcranial direct current stimulation (tDCS) and active listening therapy are safe for treating tinnitus?
Research shows that both Active Listening Therapy and transcranial Direct Current Stimulation (tDCS) have been studied for their safety in people.
Studies on Active Listening Therapy indicate it can reduce tinnitus symptoms without serious side effects. Participants reported their tinnitus was less loud and bothersome.
For tDCS, research suggests it is generally safe when used properly. This method involves applying a small electrical current to the head. The most common side effects are mild skin issues, such as tingling or itching on the scalp. Clinical trials using tDCS have reported no serious side effects.
Overall, both treatments have been well-tolerated.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the combination of Transcranial Direct Current Stimulation (tDCS) and listening therapy for tinnitus because it offers a non-invasive approach that could modulate brain activity directly. Unlike standard treatments like cognitive behavioral therapy or medication, which often focus on managing symptoms without targeting the brain's electrical activity, tDCS delivers a gentle electrical current to the scalp, potentially altering neural pathways associated with tinnitus. This mechanism, alongside listening therapy, aims to retrain the brain's response to sound, providing a unique dual-action approach that could improve outcomes for tinnitus sufferers.
What evidence suggests that this trial's treatments could be effective for tinnitus?
Research has shown that active listening therapy, one of the treatments in this trial, can greatly reduce tinnitus symptoms, such as ringing or buzzing in the ears. One study found that participants noticed a clear decrease in tinnitus loudness after using sound therapy. Another study found that longer daily use of sound therapy led to even greater improvements in how much tinnitus bothered them.
For transcranial direct current stimulation (tDCS), another treatment option in this trial, studies have also shown encouraging results. In some cases, about 73.7% of patients experienced a meaningful reduction in tinnitus symptoms after tDCS treatment. Both single and repeated sessions have demonstrated moderate to significant effects in easing tinnitus. Together, these treatments, tested in separate arms of this trial, offer hope for those dealing with tinnitus.36789Who Is on the Research Team?
Aneta Kielar, PhD
Principal Investigator
University of Arizona
Are You a Good Fit for This Trial?
This trial is for adults aged 18-80 with chronic tinnitus or hyperacusis lasting more than 8 months. It's not suitable for those with head trauma, brain surgery, psychiatric disorders, metal implants in the body (including cochlear implants), epilepsy history, other neurological conditions, specific ear diseases like Meniere's Disease or otosclerosis, and severe hearing loss.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline hearing and tinnitus assessment, MRI scan, and EEG-ERP recording
Treatment Part 1
tDCS with active listening therapy sessions
Rest and Post-Treatment Assessment
Rest period with post-treatment assessment, MRI scan, and EEG-ERP session
Treatment Part 2
tDCS with active listening therapy sessions
Rest and Post-Treatment Assessment
Rest period with post-treatment assessment, MRI scan, and EEG-ERP session
Follow-up
2-month follow-up with tinnitus assessment, MRI scan, and EEG-ERP session
What Are the Treatments Tested in This Trial?
Interventions
- Active Listening Therapy
- Sham tDCS
- Transcranial Direct Current Stimulation (tDCS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor